Business · 27/05/2015

FDA Delays Compliance Date for Electronic Submission of Postmarketing Safety Reports for Human Drugs and Biological Products

The US Food and Drug Administration (FDA) has delayed the compliance date for a rule requiring the electronic submission of postmarketing safety reports for human drugs and biological products, and has also launched a new Safety Reporting Portal (SRP) to facilitate secure electronic submissions of adverse event reports.